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Abstract:  We have developed a novel microarray technology based on total internal 
reflection fluorescence (TIRF) in combination with DNA and protein bioassays 
immobilized at the TIRF surface. Unlike conventional microarrays that exhibit reduced 
signal-to-background ratio, require several stages of incubation, rinsing and stringency 
control, and measure only end-point results, our TIRF microarray technology provides 
several orders of magnitude better signal-to-background ratio, performs analysis rapidly in 
one step, and measures the entire course of association and dissociation kinetics between 
target DNA and protein molecules and the bioassays. In many practical cases detection of 
only DNA or protein markers alone does not provide the necessary accuracy for diagnosing 
a disease or detecting a pathogen. Here we describe TIRF microarrays that detect DNA and 
protein markers simultaneously, which reduces the probabilities of false responses. 
Supersensitive and multiplexed TIRF DNA and protein microarray technology may 
provide a platform for accurate diagnosis or enhanced research studies. Our TIRF 
microarray system can be mounted on upright or inverted microscopes or interfaced 
directly with CCD cameras equipped with a single objective, facilitating the development 
of portable devices. As proof-of-concept we applied TIRF microarrays for detecting 
molecular markers from Bacillus anthracis, the pathogen responsible for anthrax. 
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1. Introduction 
The demands of various biological studies, including gene profiling, drug screening, and clinical 
diagnostics has stimulated the development of relatively simple, reliable, and high throughput methods 
allowing the detection of multiple DNA targets in a small volume of biological sample. Advanced 
detection technologies have been developed based on various analytical techniques such as 
fluorescence [1–4], surface plasmon resonance (SPR) [5], quartz crystal microbalance [6], and field 
effect transistors [7]. Among these DNA detection methods, fluorescence-based assays are currently 
the most popular techniques for multiplexed DNA detection [8,9]. Surface-enhanced Raman scattering 
(SERS) has also been considered as a promising method for multiplexed DNA detection [10,11] 
because of its molecular specificity [10,11] and insensitivity to quenching [12]. These advantages have 
led to the development of a number of SERS sensing platforms [13–15]. However, the reproducibility 
of SERS signals and ability to detect multiple target molecules in very small sample volumes is still a 
challenge for practical multiplexed SERS sensors.  
DNA microarray is a multiplex technology used in molecular biology and medicine to identify 
DNA fragments expressed in an organism or tissue [16]. It consists of an ordered series array of 
thousands of microscopic spots of DNA oligonucleotides (known as probes), each containing a few 
picomoles of different probes printed on top of silica slides [16]. Like DNA, protein arrays contain 
thousands of microspots, each of which selectively binds target proteins found in samples. In 
conventional microarrays, the probes are attached via surface engineering of the silica slides, which 
may involve covalent modifications to facilitate the adhesion of the probes to the glass surface. The 
sample is labeled using fluorescent molecules, which are later used to identify sample association to 
the probe. Typical microarray spots are 100 microns in diameter allowing the printing of thousands of 
spots in high-density arrays [17,18]. More recent (less conventional) methods of labeling samples may 
include the use of quantum dots, with the added advantage of being resilient to photo-damage [19]. 
Another relevant enhancement to the microarray technology is the recent introduction of molecular 
beacons, a technology we will use extensively during the present study. The use of molecular beacons 
eliminates the need for labeling the sample, an advantage we will discuss in greater detail later on. 
Thus, microarray is a high throughput technique, which facilitates the screening of entire 
transcriptomes using a single slide. Protein microarrays also detect multiple protein targets in   
parallel [17,20]. Simultaneous detection of nucleic acids (NA) such as DNA/RNA and protein markers 
is necessary and advantageous for numerous biomedical applications. However, the temperature and 
buffer composition for traditional NA and protein microarrays are incompatible for combined detection 
experiments. Combining NA and protein detection in single system is a challenging task [21]. 
In the present study we overcame this challenge and developed a novel combined TIRF-based 
microarray platform that detect NA and protein in the assay, at the same surface of TIRF sensor chip, 
in a single flow chamber with the same buffer and at room temperature. Sensors 2012, 12  
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This technology provides rapid results (in seconds) and renders association and dissociation   
kinetics in real time. We have named this technology LG-TIRF-MB. The use of TIRF ensures surface 
selectivity and enhanced signal-to-noise ratios, efficiently rejecting auto fluorescence from samples and 
background [22]. 
As proof-of-concept we use LG-TIRF-MB to identify DNA from Bacillus anthracis, the pathogen 
responsible for anthrax. Anthrax is an acute disease that afflicts humans. Most forms of the disease are 
lethal if not treated promptly. Anthrax has gain attention recently not only because is endemic in 
several regions of the world, but also because it has been used as a weapon in bioterrorism in recent 
years. We demonstrate also the parallel identification of model protein markers, using the same 
microarray slide. 
Furthermore, we show that studying the association and dissociation kinetics allows for the 
identification of single nucleotide mismatches in the target DNA. TIRF microarrays in conjunction 
with reagentless molecular beacons assays require minimum sample preparation and no labeling, 
facilitating the use of scarce samples, which is always a limiting factor in molecular diagnostics.  
2. Experimental Section  
2.1. Reagents and Materials 
Synthesized and purified molecular beacons, complimentary sequences, mismatched and   
non-complimentary DNA oligomers were purchased from Integrated DNA Technologies (IDT, 
Coralville, IA, USA). Biotinylated BSA, Sigmacote solution, all buffer components were purchased 
from Sigma-Aldrich (St. Louis, MO, USA), Streptavidin was purchased from Jackson Immunoresearch 
(West Grove, PA, USA). Hybridization buffer (PBST) containing 50 mM TRIS-HCl (pH 8.0), 5 mM 
KCl, 100 mM NaCl, 5 mM MgCl2 (pH 7.4) was used in all experiments reported. The reconstitution 
buffer contained in addition 4M urea. The phosphate buffered saline (PBS) contained NaCl (137 mM), 
KCl (2.7 mM), NaHPO (10 mM), KHHPO (2 mM), CaCl2, (1.8 mM, pH 7.4). 
2.2. DNA Probe Design 
The molecular beacon (MB1) was designed to target pag (protective antigen gene) residing on xo1 
plasmid of B. antracis (Table 1). The loop sequence and one side of the stem is complimentary to  
24 nucleotide fragment of pag gene in the region of diagnostic primer PA8 recommended for 
identification of B. antracis by the World Health Organization (WHO). Molecular beacons MB2 was 
designed to identify a different region form the target pag.  MB2 was used to demonstrate the 
multiplexing capacity and improved accuracy of the LG-TIRFM-MB system in combination with TIRF 
microarrays. The loop from MB2 compliments to 24 nucleotides (1,481–1,505) from the target pag. 
The molecular beacon was equipped with HEX as the fluorophore-reporter dye, BHQ1 as the 
fluorescence quencher, and a biotinylated thymidine base on the 3'- stem proximal to the quencher. 
This biotin-modified thymidine facilitated the immobilization of the beacon to the surface glass. Sensors 2012, 12  
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Table 1. Illustrates the sequences of the complementary oligonucleotides and the sequences 
of molecular beacons used in the present study. For molecular beacons the sequence 
underlined identifies the stem, and the double underlined the mistmatch introduced. HEX 
refers to the fluorophore and BHQ1 (Black Hole Quencher 1) to the quencher. 
Probe Sequence 
MB1 xo1pag (stem sequence underlined) 
5'-(5HEX) CGG GTA CAG ATG CTA TAA TCA AAG TTC 
GTG TCC ATT(Biotin-dT)AC CCG-3' 
MB2 xo1pag (stem sequence underlined) 
5'-(5HEX) CGG GTA CTA ATC TAT GCC TAG TTC ATA 
TAC(Biotin-dT)AC CCG-3' 
MB1-target complimentary DNA  
(Stem-complimentary sequence underlined) 
5'-TTT GAC ATC AAC CGT ATA TCC TTC TAC CCG-3' 
MB2-target complimentary DNA  5'-GAT TAG ATA CGG ATC AAG TAT ATG-3' 
1-base mismatched DNA (mismatch in  
double underline) 
5'-TTT GAC ATC AAC CCT ATA TCC TTC TAC CCG-3' 
2-base mismatched DNA (mismatches  
show double underline) 
5'-TTT GAC ATC AAC CCT AAA TCC TTC TAC CCG-3' 
Non-complimentary DNA (Scrambled 
sequence) 
5'-GAC TAT GCA GGT GCC GCG CGG AAA GGA TTT-3' 
The complimentary and mismatched DNA probes were designed so that six bases at the 3' are 
complimentary to the 5'- stem of the MB as it was shown to improve hybridization (Table 1). 
2.3. Sensor Surface Preparation for MB and Antibody Immobilization 
UV silica TIRF slides 25.4 mm × 76.2 mm × 1.0 mm (TIRF Technologies, Inc., Morrisville, NC, 
USA) were cleaned in chromic acid heated to 70 °C for 20 min, then rinsed with distilled water and 
air-dried. The slides were then treated with Sigmacote (Sigma, St. Louis, MO, USA) to achieve 
uniform hydrophobicity. Slides were incubated with 0.1mg/mL biotinylated BSA in PBS pH 7.4 to 
allow for adsorption of BSA to the hydrophobic surface. The slides then were rinsed extensively with 
PBS. After rinsing, the slides with irreversibly adsorbed biotinylated BSA were incubated with   
0.1 mg/mL streptavidin for 4 min to allow binding to biotin, following by rinsing with PBS. After these 
procedures, the slides were ready for printing and contained high density of biotin-binding sites 
because each streptavidin molecule contains four biotin-binding domains. 
2.4. Printing MB and Antibody Microarrays 
Molecular beacons (MB) were printed on the surface of previously prepared microarray slides (as 
described above). MB were synthesized with a biotin pendant to allow association to streptavidin 
present on the surface of the previously prepared slides.  
For antibody printing, we utilized two antibodies. Immunopure™ biotinylated mouse (antibody 1) 
and rabbit (antibody 2) anti-human IgG were purchased from ThermoScientific (cat# 31784 and 31786, 
respectively), and reconstituted to 1.5 mg/mL according to the manufacturer’s guidelines and stored at 
4 °C. For antibody microarray studies, two secondary antibodies were utilized. Alexa Fluor 532-labeled 
goat anti-mouse and goat anti-rabbit IgG antibodies were obtained from Invitrogen (cat# A11002 and Sensors 2012, 12  
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A11009, respectively), they were reconstituted to 2 mg/mL, and stored at 4 °C according to the 
supplier’s instructions.  
Printing of both, MB and antibodies was carried out using 380 micrometer pins attached to the 
BioOdyssey microarray printer (BioRad, Hercules, CA, USA). The temperature and humidity conditions 
inside the printing chamber were 25–30 °C and 60–65%, respectively. MB were printed at a final 
concentration of 0.3 μM and for antibody printing the primary antibody was used at a concentration of 
100 μg/mL. 
Post printing, the slides were briefly rinsed with 2 × 200 uL of SuperStreptavidin Blocking Buffer 
(ArrayIt, Sunnyvale, CA, USA), washed by gentle rocking in 2 × 3 mL PBST (10–30 min each) in a 
polystyrene Petri dish, rinsed with plain PBS and stored dry at 4 °C in a 50-mL disposable centrifuge 
tube until further use. 
2.5. TIRF Instrumentation 
The LG-TIRF-MB system was designed by TIRF Technologies Technologies, Inc. in collaboration 
with Angélica Zepeda and Luis Vaca. The system was mounted on top of an inverted Nikon 
microscope equipped with a 2× objective. Excitation wavelength was 532 nm using a 150 mW laser 
and emission intensity was collected at 554 nm. An iXon electron multiplied cooled (EM-CCD) 
camera (Andor Technology) was utilized for image acquisition. The camera was cooled down to   
−80 °C prior to beginning acquisition. Time-based acquisitions were obtained with time intervals of  
1 second and integration time of 0.5 seconds. Typical experiments were carried out for 12–15 minutes 
and contained hundreds of microarray images.  
2.6. Experimental Procedures and Conditions 
Every experiment consisted of the following steps controlled by the SmartFlow digital fluidics 
system (TIRF Technologies, Inc.):  
1.  Time-based acquisition of fluorescence signal was started. The background signal was 
collected for 60–80 s. 
2.  The solution of complementary, mismatched or non-complementary DNA (500 nM in 
hybridization buffer, total volume of 900 µL) was introduced into the flow cell of the LG-TIRF-
MB system using a rapid injection protocol (flow rate was 70 µL/s). During complementary 
DNA application the system acquired continuously images of fluorescence signal from the 
arrays at the TIRF surface. 
3.  Pure hybridization buffer (PBST) was dispensed throughout the flow cell for 100 s (flow rate 
12.5 µL/s) to remove non-hybridized sample.  
4.  When studying combined DNA-protein microarrays, the secondary antibody conjugated   
to Alexa 532 was applied to the chamber in PBST at a flow rate of 70 μL/s, at a final dilution  
of 5,000×. 
5.  For microarray reconstitution (regeneration), the solution contained 4 M urea (Experimental 
Section). The solution was applied during image acquisition at a rate of 70 μL/s. The flow was Sensors 2012, 12  
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interrupted after fluorescence reached background levels, indicating the microarray was fully 
reconstituted and ready for the next cycle of sample application. 
3. Results and Discussion  
3.1. Design of the LG-TIRF-MB System 
We have developed an add-on system (Figure 1) which can be mounted on top of any inverted 
microscope and use virtually any light source to produce the evanescent wave (EW) needed for total 
internal reflection fluorescence (TIRF).  
Figure 1. Implementation of the LG-TIRF-MB system. (A) Illustration of the different 
components forming the LG-TIRFM-MB system. Any light source coupled to the mm fiber 
optic is directed to the beam conditioner (TAC) resulting in a change from “spot-geometry” 
into “line geometry” of the excitation beam at the TAC outlet. Light sources include light 
emitting diodes (LEDs), halogen, mercury lamps or lasers. The fiber optic bundle at the 
end of the TAC couples the excitation light to the slide, which carries DNA-protein 
microarray at its upper surface. Light then travels bouncing up and down the facet of the 
slide. At the top of the slide, the light reflecting at the silica/water interface at angles larger 
than critical produces the evanescent wave. The closed chamber where the microarray is 
contained facilitates injection of sample bioanalyte solutions and washing procedures.   
At the bottom of the system is located the low magnification objective (typically 2× or 
less) and an emission filter. An EM-CCD camera is attached to the microscopy port.   
The photograph (inset) shows a picture of one microarray slide above the objective.   
(B) Photograph of the actual system showing the tubing used for perfusion, fiber optic 
bundle, TAC and microarray slide mounted in the (hermetically sealed) closed chamber.  
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Figure 1. Cont.  
 
 
The use of low magnification (2×) objectives facilitates the visualization of the entire microarray. In 
the present study we used silica slides, but the system is capable of using conventional microarray 
glass slide (1 mm thick) as light-guide to produce and disperse the evanescent wave (EW). The system 
is factory-aligned and the incident angle is fixed to a value larger than critical, ensuring reproducible 
illumination of the microarray in total internal reflection mode. The system is equipped with a closed 
flow cell to facilitate the rapid addition of samples and rinsing procedures. Since we use the microarray 
slide as a TIRF lightguide and molecular beacons as reagentless assays, we have named the system 
Lightguide-based TIRF (LG-TIRF-MB). We have described the technical details of light-guided TIRF 
elsewhere [23]. 
Because the EW decays exponentially with the distance from the slide surface, only fluorophores 
located at or near the surface of the slide are excited and fluoresce [24]. Thus, TIRF is a surface 
selective technique, which renders information only from a shallow (submicron) area near the slide 
(typically less than 100 nm) [25]. Surface selectivity prevents auto fluorescence commonly associated 
with biological samples, while enhancing signal-to-noise ratios, both important elements when 
considering point-of-care diagnostic (POCD) systems.  
The LG-TIRF-MB system consists of fiber optics adapter and beam conditioner (TAC) and a   
slide-lightguide (Figure 1). TAC is a custom designed fiber optics bundle, which converts   
“spot-geometry” of the excitation beam from any illuminator (at the inlet of TAC) into “line   
geometry” of the excitation beam at the TAC outlet. This part of the system is essential to ensure even 
distribution of the EW along the slide/lightguide. Light propagates through the microarray slide 
entering the TIRF slide line-end of TAC via the thin edge (1 mm × 25.4 mm) of the rectangular slide 
(25.4 mm × 76.2 mm × 1 mm). Approximately 90% of the excitation beam reflects from the top and 
bottom surfaces of the slides at angles larger than critical (for water/glass interfaces about 61.7°). The 
beam is approximately 16 mm wide at the center of a 25.4 mm × 76.2 mm slide. This provides a 
sufficiently wide and uniform EW to excite all the spots on the microarray simultaneously. A CCD 
camera is coupled to the microscope to collect the fluorescent signal from the microarray.  
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3.2. A Robust and Reusable Microarray System  
DNA-based molecular beacons (MB) and antibodies were printed as low-density arrays on the 
surface of silica microscopy slides (Material and Methods, see also supplementary material Figure S1). 
The diameter of each spot was approximately 400 microns, and the pitch 600 microns. At this density 
several dozen printed spots could be visualized simultaneously with our LG-TIRF-MB system using a 
conventional 2× objective.  
Conventional microarray technology includes incubation steps in which the sample is heated to 
facilitate the association to the probe printed on the microarray glass surface. The LG-TIRF-MB 
technology is designed to facilitate the association between target and MB occurring at room 
temperature. In order for target-MB association to occur at room temperature, molecular beacons must 
be designed paying special attention to the stem and length of the MB loop and stem complementarity, 
according to previously published rules [25].  
Figure 2(A) illustrates the time course of MB1 fluorescence intensity increment in response to 
target addition (pag, protective antigen, gene sequence from anthrax) at room temperature. As 
illustrated in the figure, multiple replicate samples could be monitored simultaneously showing a 
robust increment in fluorescence upon target application (Figure 2(A,B), and supplementary video 1). 
Plotting x-y fluorescence against time provided in a single picture the entire history of the experiment 
(Figure 1(B)). This technique facilitates the visualization of the entire time course in a single image, 
and therefore will be extensively used in following figures. 
Furthermore, the target could be dissociated and washed out from the microarray using the rinsing 
solution, resulting in the reconstitution of the microarray (Figure 2(B,C) and supplementary video 1). 
Using this procedure multiple sample applications on the same microarray could be performed   
(Figure 2(B), for simplicity only two repetitions are shown). Measuring fluorescence intensity over 
time provides target-MB association kinetics, which was reproducible among different applications 
(Figure 2(C)).  
By using two MB designed to identify different regions from the pag (protective antigen) gene 
sequence from anthrax (Table 1, Experimental Section) we illustrate the identification of independent 
DNA signatures in targets (phenomenon named multiplexing). Multiplexing is extremely important to 
reduce the probability of false positives responses in microarray studies. Printing both molecular 
beacons (MB1 and MB2) on the same TIRF microarray in replicates shows the selectivity of this 
technique (supplementary video 1). Each MB produced fluorescence signal only when the respective 
complimentary oligonucleotide target was injected into the closed flow cell. Using a scramble DNA 
sequence (Material and Methods) did not affect MB fluorescence, illustrating the selectivity of the 
molecular beacons, something that was demonstrated since the first MB report [25]. 
Using different target concentrations provided the detection limit of the system. According to our 
results this method, using the particular configuration of LG-TIRFM-MB system described in this 
article, can detect targets in the picoMolar range (supplementary material Figure S2). One of the key 
factors in detecting low concentrations is the use of a very sensitive EM-CCD camera, and a powerful 
light source for excitation to produce a robust EW.  Sensors 2012, 12  
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Figure 2. Typical microarray experiment using the LG-TIRF-MB system. (A) Picture of 
the viewing area accessible to the 2x objective (the image shows 30 spots). (B) Time 
course of the microarray activation upon DNA sample addition. Notice the reproducibility 
of the response when all spots show increments in fluorescence with similar time courses. 
The fluorescence was plotted X-Y and time to illustrate the entire experiment in one image. 
Pseudo-color was used to evidence all changes in fluorescence (scale shown on the right). 
Green arrows point to the time of DNA sample application and fuchsia arrows indicate the 
time of microarray reconstitution (Wash). For simplicity in this particular experiment the 
microarray was reconstituted twice, even though we have accomplished near to 10 times 
reutilization of the same microarray. (C) Time courses showing changes in mean 
fluorescence of each spot as lines. First and second sample application are indicated with 
green arrows.  
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3.3. Measuring Realtime Association Kinetics in  DNA-Protein Combined Microarrays 
Figure 3 demonstrates an example of the use of DNA-protein combined microarrays. In this 
particular slide, spots were printed with MB1 to detect gene pag from anthrax, while other spots were 
printed with a primary antibody 1 used as a model protein for detection (Experimental Section). 
Figure 3. Combined DNA and protein microarrays on the same slide. (A) Example of a 
typical response obtained in a combined microarray using DNA and antibodies. The three 
spots at the top are molecular beacons for pag and the three bottom spots of Immunopure™ 
biotinylated mouse anti-human IgG. (B) Time course of the microarray response to 
bioanalyte solutions. First DNA from pag was applied (green arrow), followed by the 
secondary antibody (Alexa Fluor 532-labeled goat anti-mouse IgG, red arrow). Notice that 
even though the secondary antibody floods the entire chamber, only the spots containing 
the primary antibody produced a fluorescent signal. This simple experiment demonstrates 
the power of surface selectivity obtained with LG-TIRFM-MB. Microarray reconstitution 
brings the fluorescence towards baseline (pre stimulation) levels. At the right of the figure 
is shown the fluorescence intensity scale. (C) Lines depict time courses showing changes 
in mean fluorescence of each spot over time. Time points where DNA and antibody were 
applied are indicated by the arrows.  
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To identify the antibody printed on the surface of the slide, a secondary antibody conjugated to the 
fluorophore Alexa 532 was utilized. Most interestingly, despite having the entire chamber bathed with 
the secondary fluorescent antibody, no background fluorescence was detected; only the fluorescence 
arising from the spot containing the first antibody was detected (antigen, Figure 3(B)). This experiment 
demonstrates the power of surface selectivity obtained with LG-TIRF-MB, which ensures that the bulk 
solution is not excited by the EW (the solution containing the secondary antibody), effectively 
reducing background fluorescence.  
As illustrated in Figure 3(C), the combined DNA-protein TIRF microarray can be regenerated also 
using the same rinsing solution (Experimental Section). Using multiple replicate spots of the same 
probes demonstrates the robustness and reproducibility of the response in the TIRF microarray 
platform (Figure (3) and supplemental video 2). 
Furthermore, we printed slides using two different primary antibodies to explore the possibility of 
identifying independent proteins in the same microarray slide. As illustrated in supplementary video 3, 
using different secondary antibodies we could identify different antigens (primary antibodies) printed 
on the TIRF slide in the same experiment. Most interestingly, we used the same fluorophore on both 
secondary antibodies (Alexa 532), but were able to identify the positive signal based on position of the 
different spots on the microarray slide. Because the excitation wavelength can be easily switched in the 
LG-TIRF-MB, one can envision more complex experiments utilizing multiple fluorophores with 
different excitation and emission spectra to identify simultaneously independent DNA and proteins 
present in samples of interest. 
3.4. Association Kinetics Allows the Discrimination of Single Nucleotide Mismatches 
One important feature on any POCD system is the ability to identify single nucleotide polymorphisms 
or mutations [26]. We were interested in exploring the selectivity limits of LG-TIRF-MB technology 
and to do so we designed experiments aimed to identify single and multiple nucleotide mismatches on 
the target via association kinetic analysis. In order to explore this, we introduced one or two mismatches 
in the pag (protective antigen) gene sequence from Anthrax (Material and Methods) and use these 
oligonucleotides with the MB1 molecular beacon (Experimental Section).  
In Figure 4(B) we show that using a 3D rendering technique facilitates visualizing the entire time 
course of the experiment in all the microarray spots in three dimensions (x-y and time). Combining the 
3D rendering technique with pseudo-color provides a clear picture of the differences in the time 
courses for the association of the target to the different MB utilized in this experiment. 
As illustrated in Figure 4(C), using LG-TIRF-MB technology was relatively simple to identify 
single and multiple mismatches by comparing target-MB association kinetics. This simple experiment 
demonstrates the flexibility and usefulness of measuring kinetics in microarrays. 
Another important part of this new technology is the ability to print internal controls on the 
microarray. By doing this it is possible to normalize fluorescence response and mitigate for variations 
of excitation intensity, minimize false positives and also use internal controls to produce   
semi-quantitative results based on the fluorescence intensity obtained on each spot from the array. Sensors 2012, 12  
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Figure 4. Identifying mismatches based on association kinetics from the micorarray.   
(A) Images obtained at different time points illustrating increments in fluorescence upon 
addition of three samples (DNA for pag). Samples are: perfect match to MB1, sample with 
one mismatch and sample with two mismatches (see Experimemtal Section for sequences). 
(B) Tridimensional rendering plot illustrating the entire microarray experiment time course 
in one image. This is a volumetric image plotting the changes in fluorescence overtime of 
each spot in 3D (x-y versus time). Pseudo-color was utilized to enhance even the smallest 
increment in fluorescence, making it easier to identify. The triplicate spots for perfect 
match, one and two mismatches are illustrated. (C) Time courses showing changes in mean 
fluorescence of each spot as lines overtime for perfect match (black lines), one mismatch 
(green lines) and two mismatches (red lines). Each line represents the mean fluorescence of 
one spot over time. Notice that the more mismatches present, the slower the increment in 
fluorescence. 
 
4. Conclusions  
Microarray technology has been present for the last fifteen years since the first developments of 
DNA in arrays for expression profiling described in 1995 [27]. Since those initial studies there have 
been several improvements and development of new systems for microarray technology.  
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New developments include the use of molecular beacons [28] and the design of protein microarray 
technology (for a review see [29]). Recent studies have shown the development of TIRF-based systems 
for microarray studies using microscopic beads [30]. Other new developments include the design of 
fiber optic microarrays [5] and the combination of microarrays with micro-fluidics [31].  
The use of microarrays in medicine has been gaining attention in the last few years. Several studies 
highlight the advantage of microarray technology in pathogen detection and biodefense (for review  
see [13,32]), molecular diagnostics [15], single nucleotide polymorphisms (SNP) and mutation 
analysis [33], and cancer [34], among many others. Several of these studies point to the need of robust 
microarray technologies for POCD. 
In the present study we report the development of a novel TIRF-based microarray technology for 
the identification of nucleic acids and proteins in the same microarray slide. For this purpose we utilize 
molecular beacons in combination with antibodies to print at low density on conventional microarray 
glass slides.  
We used this combined DNA-protein microarrays in conjunction with a novel total internal 
reflection fluorescence system to integrate the microarray technology. This technology provides 
association and dissociation kinetics between target molecules and probes, which is useful in the 
discrimination of mismatches or to quantify the affinity of antibodies to antigens. By using internal 
controls with samples of known concentrations it is feasible to produce quantitative results. 
Worth special mention, the technology described here can be easily extended for the identification 
of low molecular weight organic metabolites. In preliminary studies we have printed fluorescent assays 
for detection of cAMP, tryptophan and biotin. Similar strategies could be implemented for the 
identification of recognition elements for lipids, sugars or other metabolites. 
Most importantly, this novel technology requires minimum sample preparation and no sample 
labeling, making it ideal for POCD. Furthermore, results from the microarray experiment are obtained 
in a few seconds, unlike conventional microarray technology, which requires several hours [35]. The 
speed is achieved by using TIRF technology to read the entire microarray simultaneously using a CCD 
camera, unlike conventional microarray readers which use confocal microscopy or scanners to read 
point-by-point the entire microarray [35].  
Conventional microarray readers have lower single-to-noise ratios when compared to LG-TIRF-MB 
because confocal microscopy has a penetration depth of about 1 micron, whereas TIRF excites only a 
narrow area (approximately 100 nm) above the surface glass [22]. Any autofluorescence arising from 
bulk solution is discarded with LG-TIRF-MB (as clearly illustrated in Figure 3).  
There are also limitations related to the use of LG-TIRF-MB. Firstly, because the system produces a 
wide EW (approximately 16 mm wide) all the optical power is diluted in a relatively large area (which 
is required to excite the entire microarray at once), therefore relatively powerful excitation light source 
is required (typically of 250 mW or more), to reach the detection limit determined by photostability of 
organic fluorophores. This limitation is significantly reduced in trough-objective TIRF (o-TIRF) 
systems where all the optical power is concentrated in a few microns. However, because the critical 
angle in o-TIRF can only be achieved using high numeric aperture/high magnification objectives,   
o-TIRF technology cannot be used for microarray studies where low magnification objectives are 
required. The decrease in intensity of the EW along the TIRF slide does not affect significantly the Sensors 2012, 12  
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results, since only a small (less than 2%) reduction in EW intensity are typically observed at the end of 
the slide/lightguide [23].  
Because in LG-TIRF-MB there is no scanning of the microarray pixel-by-pixel unlike in 
conventional microarray readers, this technology is limited to the viewing area attained by the 
objective. Using a low magnification objective approximately 60–100 spots can be visualized at once 
(depending on the spot diameter). This low-density microarray contrasts with the thousands of spots 
scanned on conventional high-density microarray platforms. Thus LG-TIRF-MB may be more 
appropriate for POCD or applications where exploring entire transcriptomes (or thousands of probes) 
is not required. 
The limit of detection of LG-TIRF-MB for DNA and RNA targets is larger than that for PCR-based 
methods, yet the capability of simultaneous detecting DNA, RNA, protein, and metabolite markers (a 
task we can conduct routinely with LG-TIRF-MB) represents significant advantages of   
LG-TIRF-MB over traditional methods. Recent developments in PCR using CCD and in-gel 
technologies to analyze the results provide extended advantages to conventional PCR [36], yet detecting 
only DNA and RNA markers remains the major limitation of PCR-based techniques. The other 
advantage of LG-TIRF-MB when compared to PCR-based methods is that results are obtained in 
seconds, whereas PCR methods may require hours. 
Finally, use of a very sensitive camera might be necessary to identify targets present at low 
concentration in samples. In theory, LG-TIRF-MB can detect single molecule fluorescence; however 
this level of sensitivity can be achieved only using low light EM-CCD cameras, like the one used in 
the present study. 
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